Opthamology @Point of Care Podcasts

S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

25 min · 7. heinä 2026
jakson S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD kansikuva

Kuvaus

Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD. Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD [https://suitehome.atpointofcare.com/library/2707.01/page/0?subdomain=dr\&time=1336000\&pre=skip\&utm_source=podcast] to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast [https://pinecast.com].

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Opthamology @Point of Care Podcasts-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

8 jaksot

jakson S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD kansikuva

S1E5 - Ophthalmology Morning Commute : Optimizing Second-Generation Anti-VEGF Agents for nAMD

Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD. Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD [https://suitehome.atpointofcare.com/library/2707.01/page/0?subdomain=dr\&time=1336000\&pre=skip\&utm_source=podcast] to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast [https://pinecast.com].

7. heinä 202625 min